Published in J Acquir Immune Defic Syndr on January 01, 1992
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci U S A (2002) 17.22
Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med (1992) 3.40
HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood (2006) 2.95
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab (2006) 1.72
Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection. J Clin Immunol (2001) 1.56
Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle. J Virol (1995) 1.54
Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res (2011) 1.29
HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses (2010) 1.26
HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvasc Res (2008) 1.17
Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. J Virol (2001) 1.17
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med (2008) 1.14
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol (1996) 1.09
HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology (2013) 1.04
Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol (2008) 1.02
Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. AIDS Res Hum Retroviruses (2010) 1.02
Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. Blood (2005) 0.99
CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J Exp Med (1998) 0.99
Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. Am J Pathol (2001) 0.99
HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. Cardiovasc Res (2010) 0.98
Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am J Physiol Heart Circ Physiol (2008) 0.97
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity. EBioMedicine (2015) 0.94
HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha. Immunology (1996) 0.91
Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites. J Virol (2009) 0.89
Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120. J Virol (2004) 0.88
Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy. J Virol (2009) 0.88
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics. Chem Rev (2015) 0.88
Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors. PLoS One (2013) 0.87
The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions. J Physiol (2012) 0.86
Cytotoxic effect of HIV-1 gp120 on primary cultured human retinal capillary endothelial cells. Mol Vis (2011) 0.85
Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes. Clin Exp Immunol (2003) 0.85
HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One (2014) 0.85
Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. J Clin Invest (1994) 0.84
HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med (2012) 0.83
Nuclear phosphoinositide-specific phospholipase C β1 controls cytoplasmic CCL2 mRNA levels in HIV-1 gp120-stimulated primary human macrophages. PLoS One (2013) 0.82
Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. Retrovirology (2013) 0.81
Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells. PLoS Pathog (2013) 0.80
Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120. J Clin Invest (1997) 0.79
Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development. Pulm Circ (2013) 0.79
Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor. J Clin Invest (1997) 0.79
Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation. J Neuroinflammation (2014) 0.78
HIV-1 impairs human retinal pigment epithelial barrier function: possible association with the pathogenesis of HIV-associated retinopathy. Lab Invest (2014) 0.78
Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J Cardiol (2015) 0.77
Effects of HIV-1 gp120 and protease inhibitors on apoptotic susceptibility of CD34+ hematopoietic progenitor cells. J Acquir Immune Defic Syndr (2011) 0.77
Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization. PLoS One (2015) 0.77
Envelope glycoprotein (gp120) from HIV-1 enhances Mycobacterium avium growth in human bronchoalveolar macrophages; an effect mediated by enhanced prostaglandin synthesis. Clin Exp Immunol (1994) 0.77
Surfactant Protein D modulates HIV infection of both T-cells and dendritic cells. PLoS One (2013) 0.76
Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site. J Virol (2017) 0.75
Methamphetamine potentiates HIV-1 gp120-mediated autophagy via Beclin-1 and Atg5/7 as a pro-survival response in astrocytes. Cell Death Dis (2016) 0.75
HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes. PLoS One (2017) 0.75
Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring. Adv Drug Deliv Rev (2016) 0.75
HIV Glycoprotein Gp120 Impairs Fast Axonal Transport by Activating Tak1 Signaling Pathways. ASN Neuro (2016) 0.75
Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder. J Neurovirol (2015) 0.75
Proteomics, biomarkers, and HIV-1: A current perspective. Proteomics Clin Appl (2015) 0.75
Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease. Tissue Barriers (2016) 0.75
Fate of microglia during HIV-1 infection: From activation to senescence? Glia (2016) 0.75
Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science (1996) 5.44
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum (1993) 5.05
The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol (1970) 4.62
A highly conserved repeated DNA element located in the chromosome of Streptococcus pneumoniae. Nucleic Acids Res (1992) 3.73
Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens. J Exp Med (1970) 3.55
Acquired immunodeficiency syndrome in New York City. Evaluation of an active surveillance system. JAMA (1985) 3.45
Is phimosis overdiagnosed in boys and are too many circumcisions performed in consequence? Ann R Coll Surg Engl (1989) 3.23
Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol (2000) 3.19
Worthing physiological scoring system: derivation and validation of a physiological early-warning system for medical admissions. An observational, population-based single-centre study. Br J Anaesth (2007) 2.98
Women prefer hospital births. BMJ (1992) 2.88
Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun (1997) 2.85
T-lymphocyte subpopulations in homosexual men. N Engl J Med (1982) 2.72
Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (1987) 2.61
Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol (1998) 2.55
Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA (1989) 2.53
The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1978) 2.30
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab (2003) 2.29
Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care (1998) 2.25
Bacteriophytochromes are photochromic histidine kinases using a biliverdin chromophore. Nature (2001) 2.22
HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes (2001) 2.18
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16
Lymphocyte activation by HIV-1 envelope glycoprotein. Nature (1988) 2.15
Increasing the rate of chromatin remodeling and gene activation--a novel role for the histone acetyltransferase Gcn5. EMBO J (2001) 2.04
Increasing prevalence of obesity in primary school children: cohort study. BMJ (2001) 2.04
The Wessex Growth Study: first report. Acta Paediatr Scand Suppl (1989) 2.02
Where next for prophylaxis against pre-eclampsia? Br J Obstet Gynaecol (1996) 1.95
Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol (1988) 1.95
Studies on the Toxemia Syndrome After Burns II: Central Nervous System Changes as a Cause of Death. Ann Surg (1945) 1.89
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess (2001) 1.87
Predicting length of stay, functional outcome, and aftercare in the rehabilitation of stroke patients. The dominant role of higher-order cognition. Stroke (1993) 1.73
The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol (1975) 1.71
Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science (1992) 1.69
The relationship between beliefs about nutrition and dietary practices of the elderly. J Am Diet Assoc (1990) 1.67
A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci U S A (1997) 1.67
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A (1994) 1.65
Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res (1995) 1.65
Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun (1989) 1.64
Effect of preoperative anaesthetic visit on anxiety. Br Med J (1977) 1.64
Colorectal carcinoma in children and adolescents--a report of seven cases. Eur J Pediatr Surg (2001) 1.64
Diagnosis of malaria in a remote area of the Philippines: comparison of techniques and their acceptance by health workers and the community. Bull World Health Organ (2001) 1.63
An assessment of the accuracy of clinical diagnosis, local microscopy and a rapid immunochromatographic card test in comparison with expert microscopy in the diagnosis of malaria in rural Kenya. Trans R Soc Trop Med Hyg (2000) 1.62
Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol Biochem Parasitol (2000) 1.62
Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care (1993) 1.60
Interleukin-16. J Leukoc Biol (2000) 1.59
Mitogenicity of bacterial endotoxins: characterization of the mitogenic principle. J Immunol (1973) 1.59
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58
Rectal examination in paediatric surgical practice. Br J Surg (1999) 1.58
Lymphokine activation of T4+ T lymphocytes and monocytes. J Immunol (1987) 1.58
Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun (1994) 1.57
Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J Med Microbiol (2000) 1.57
Human health implications of environmental contaminants in Arctic Canada: a review. Sci Total Environ (1999) 1.57
Defective T-cell response in beige mutant mice. Nature (1982) 1.56
Relief from chronic pain by low power laser irradiation. Neurosci Lett (1983) 1.56
Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol (1972) 1.55
Effects of aging on the differentiation and proliferation potentials of cells of the immune system. Fed Proc (1975) 1.53
Cellular recognition by mouse lymphocytes in vitro. II. Specific stimulation by histocompatibility antigens in mixed cell culture. J Immunol (1970) 1.53
Macrophage apoptosis in mycobacterial infections. J Leukoc Biol (1999) 1.51
Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet (2002) 1.50
Bacterial identification by microcalorimetry. Nature (1973) 1.49
Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol (2003) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod (2012) 1.46
Fatal thrombotic thrombocytopenia purpura presenting with choroidal vasculopathy and serous retinal detachment. Eye (Lond) (2005) 1.46
Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans. J Immunol (1981) 1.43
Vbeta8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen-specific IgE in a murine model of allergic asthma. Clin Exp Allergy (1998) 1.43
Schistosomiasis in Australian travellers to Africa. Med J Aust (1997) 1.43
An interstate drowning study. Am J Public Health Nations Health (1968) 1.42
The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med (1993) 1.41
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem (2000) 1.40
Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity. J Exp Med (1973) 1.39
Induction for rapid sequence induction: a tri-deanery survey. Anaesthesia (2012) 1.39
Repeated immunization: possible adverse effects. Reevaluation of human subjects at 25 years. Ann Intern Med (1974) 1.39
Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem (1994) 1.38
Homology of cryptic plasmid of Neisseria gonorrhoeae with plasmids from Neisseria meningitidis and Neisseria lactamica. J Clin Pathol (1986) 1.38
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer (2011) 1.38
Double-blind study of lorazepam and diazepam in status epilepticus. JAMA (1983) 1.37
Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme. J Biol Chem (1979) 1.37
Lymphocyte recruitment to the lung. Am Rev Respir Dis (1990) 1.37
Induction of human T lymphocyte motility by interleukin 2. J Immunol (1985) 1.35
Interleukin 16 and its function as a CD4 ligand. Immunol Today (1996) 1.34
Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem (1998) 1.34
TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb) (2002) 1.33
Rapid virological surveillance of community influenza infection in general practice. BMJ (2000) 1.31
Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr (1993) 1.30
The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant. J Gen Virol (1992) 1.30
Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol (1992) 1.28
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet (1986) 1.26
Historical population movements in Europe influence genetic relationships in modern samples. Hum Biol (1996) 1.23
Mood assessment in chronic pain patients. Disabil Rehabil (1994) 1.23
Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect (2010) 1.23
Dual roles of p82, the clam CPEB homolog, in cytoplasmic polyadenylation and translational masking. RNA (1999) 1.21
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clin Infect Dis (1999) 1.20
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20